BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19741597)

  • 21. Spatial distribution of LTi-like cells in intestinal mucosa regulates type 3 innate immunity.
    Sécca C; Bando JK; Fachi JL; Gilfillan S; Peng V; Di Luccia B; Cella M; McDonald KG; Newberry RD; Colonna M
    Proc Natl Acad Sci U S A; 2021 Jun; 118(23):. PubMed ID: 34083442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cutting edge: Uniqueness of lymphoid chemokine requirement for the initiation and maturation of nasopharynx-associated lymphoid tissue organogenesis.
    Fukuyama S; Nagatake T; Kim DY; Takamura K; Park EJ; Kaisho T; Tanaka N; Kurono Y; Kiyono H
    J Immunol; 2006 Oct; 177(7):4276-80. PubMed ID: 16982861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity.
    Colonna M
    Immunity; 2009 Jul; 31(1):15-23. PubMed ID: 19604490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis.
    Ciccia F; Accardo-Palumbo A; Alessandro R; Rizzo A; Principe S; Peralta S; Raiata F; Giardina A; De Leo G; Triolo G
    Arthritis Rheum; 2012 Jun; 64(6):1869-78. PubMed ID: 22213179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammation-induced formation of fat-associated lymphoid clusters.
    Bénézech C; Luu NT; Walker JA; Kruglov AA; Loo Y; Nakamura K; Zhang Y; Nayar S; Jones LH; Flores-Langarica A; McIntosh A; Marshall J; Barone F; Besra G; Miles K; Allen JE; Gray M; Kollias G; Cunningham AF; Withers DR; Toellner KM; Jones ND; Veldhoen M; Nedospasov SA; McKenzie ANJ; Caamaño JH
    Nat Immunol; 2015 Aug; 16(8):819-828. PubMed ID: 26147686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-22-producing innate immune cells: new players in mucosal immunity and tissue repair?
    Vivier E; Spits H; Cupedo T
    Nat Rev Immunol; 2009 Apr; 9(4):229-34. PubMed ID: 19319141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease.
    Liu Z; Yang L; Cui Y; Wang X; Guo C; Huang Z; Kan Q; Liu Z; Liu Y
    Inflamm Bowel Dis; 2009 Aug; 15(8):1133-44. PubMed ID: 19322899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The chemokine receptor CXCR5 is pivotal for ectopic mucosa-associated lymphoid tissue neogenesis in chronic Helicobacter pylori-induced inflammation.
    Winter S; Loddenkemper C; Aebischer A; Räbel K; Hoffmann K; Meyer TF; Lipp M; Höpken UE
    J Mol Med (Berl); 2010 Nov; 88(11):1169-80. PubMed ID: 20798913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intestinal Lin- c-Kit+ NKp46- CD4- population strongly produces IL-22 upon IL-1β stimulation.
    Lee Y; Kumagai Y; Jang MS; Kim JH; Yang BG; Lee EJ; Kim YM; Akira S; Jang MH
    J Immunol; 2013 May; 190(10):5296-305. PubMed ID: 23589614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense.
    Satoh-Takayama N; Vosshenrich CA; Lesjean-Pottier S; Sawa S; Lochner M; Rattis F; Mention JJ; Thiam K; Cerf-Bensussan N; Mandelboim O; Eberl G; Di Santo JP
    Immunity; 2008 Dec; 29(6):958-70. PubMed ID: 19084435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prion protein-deficient mice exhibit decreased CD4 T and LTi cell numbers and impaired spleen structure.
    Kim S; Han S; Lee YE; Jung WJ; Lee HS; Kim YS; Choi EK; Kim MY
    Immunobiology; 2016 Jan; 221(1):94-102. PubMed ID: 26299705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CXCL13 responsiveness but not CXCR5 expression by late transitional B cells initiates splenic white pulp formation.
    Neely HR; Flajnik MF
    J Immunol; 2015 Mar; 194(6):2616-23. PubMed ID: 25662995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of CXCL13 in asthma: novel therapeutic target.
    Baay-Guzman GJ; Huerta-Yepez S; Vega MI; Aguilar-Leon D; Campillos M; Blake J; Benes V; Hernandez-Pando R; Teran LM
    Chest; 2012 Apr; 141(4):886-894. PubMed ID: 22016489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lineage relationship analysis of RORgammat+ innate lymphoid cells.
    Sawa S; Cherrier M; Lochner M; Satoh-Takayama N; Fehling HJ; Langa F; Di Santo JP; Eberl G
    Science; 2010 Oct; 330(6004):665-9. PubMed ID: 20929731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut.
    Sonnenberg GF; Monticelli LA; Elloso MM; Fouser LA; Artis D
    Immunity; 2011 Jan; 34(1):122-34. PubMed ID: 21194981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CXCR5 expressing human central memory CD4 T cells and their relevance for humoral immune responses.
    Chevalier N; Jarrossay D; Ho E; Avery DT; Ma CS; Yu D; Sallusto F; Tangye SG; Mackay CR
    J Immunol; 2011 May; 186(10):5556-68. PubMed ID: 21471443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Children's immunology, what can we learn from animal studies (3): Impaired mucosal immunity in the gut by 2,3,7,8-tetraclorodibenzo-p-dioxin (TCDD): a possible role for allergic sensitization.
    Ishikawa S
    J Toxicol Sci; 2009; 34 Suppl 2():SP349-61. PubMed ID: 19571490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjögren's syndrome.
    Amft N; Curnow SJ; Scheel-Toellner D; Devadas A; Oates J; Crocker J; Hamburger J; Ainsworth J; Mathews J; Salmon M; Bowman SJ; Buckley CD
    Arthritis Rheum; 2001 Nov; 44(11):2633-41. PubMed ID: 11710719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dendritic cells produce CXCL13 and participate in the development of murine small intestine lymphoid tissues.
    McDonald KG; McDonough JS; Dieckgraefe BK; Newberry RD
    Am J Pathol; 2010 May; 176(5):2367-77. PubMed ID: 20304952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel CXCL13 transgenic mouse: inflammation drives pathogenic effect of CXCL13 in experimental myasthenia gravis.
    Weiss JM; Robinet M; Aricha R; Cufi P; Villeret B; Lantner F; Shachar I; Fuchs S; Souroujon MC; Berrih-Aknin S; Le Panse R
    Oncotarget; 2016 Feb; 7(7):7550-62. PubMed ID: 26771137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.